Medacta Corporate
GMK Sphere awarded 3A* ODEP rating

GMK Sphere awarded 3A* ODEP rating

Medacta is proud to announce that GMK Sphere was awarded the 3A* ODEP rating, confirming the excellent survival rate of the implant (latest ODEP ratings can be found at www.odep.org.uk).

 

According to the Orthopaedic Data Evaluation Panel (ODEP) rating criteria, GMK Sphere has been evaluated in a minimum cohort of 150 knees, demonstrating Kaplan-Meier survivorship data in line with cumulative percent of revision lower than 5% at ten years. The ODEP rating is not awarded based only on a specific study (with selected surgeons), rather it comes from nationwide data of English and Welsh hospitals.
 
This excellent rating is confirmed and outmatched by the 3 years preliminary clinical outcomes of the GMK Sphere ODEP study (performed in four centers in the UK and Belgium). At three years follow-up, the implant demonstrates excellent survival with a survival rate of 99.72%. Both objective and subjective outcomes show consistent optimal values and witness the efficacy of the GMK Sphere to achieve excellent clinical results and patient satisfaction.